Project : PXD000531



Human pleural effusion LC-MSMS


We screened pleural effusion proteomes of mesothelioma and lung adenocarcinoma patients to identify novel soluble mesothelioma biomarkers. We performed quantitative mass spectrometry-(MS-) based proteomics using isobaric tags for relative and absolute quantification (iTRAQ) and used narrow range immobilized pH gradient/high resolution isoelectric focusing (IPG/HiRIEF; pH 4 to 4.25) prior to analysis by nano liquid chromatography-coupled MS/MS. Pleural effusions from patients with malignant mesothelioma (n=6), lung adenocarcinoma (n=6), or benign mesotheliosis (n=7) were analyzed, and more than 1,300 proteins were identified.

Sample Processing Protocol

See details in reference PMID : 24361865

Data Processing Protocol

See details in reference PMID : 24361865


Filip Mundt, Karolinska Institutet

Submission Date



Not available


LTQ Orbitrap Velos


Not available

Experiment Type

Bottom-up proteomics


    Mundt F, Johansson H, Forshed J, Arslan S, Metintas M, Dobra K, Lehtio J, Hjerpe A. Proteome screening of pleural effusions identifies galectin 1 as a diagnostic biomarker and highlights several prognostic biomarkers for malignant mesothelioma. Mol Cell Proteomics. 2013 Dec 20 PubMed(s) : 24361865

You are about to run PRIDE Inspector via Java Web Start. Double click on the JNLP file downloaded if it didn't start automatically.

Note: Due to Oracle's recent Java update, you may experience security related problems with Java Web Start. Please add "" to the URLs listed in the Security tab of your Java Control Panel.